Clinical Trial Update: Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and immunogenicity of an MVA-based HIV vaccine in HIV-uninfected adults; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Modified Vaccinia Ankara (MVA) HIV vaccine (Modified Vaccinia Ankara-based HIV vaccine)

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV Infection | Phase 1 | Status: COMPLETED